Scientific Publication

Apoptosis induction by siRNA targeting integrin-β1 and regorafenib/DDAB-mPEG-PCL hybrid nanoparticles in regorafenib-resistant colon cancer cells

Journal: American Journal of Cancer Research
Year: 2021
Impact Factor: 5.94

Abstract

Zhiani M, Mousavi MA, Rostamizadeh K, Pirizadeh R, Osali A, Mennati A, Motlagh B, Fathi M (2021). siRNA + regorafenib hybrid nanoparticles trigger apoptosis in regorafenib-resistant colon cancer.


Detailed Discussion & Nanotech Implementation

Zhiani M, Mousavi MA, Rostamizadeh K, Pirizadeh R, Osali A, Mennati A, Motlagh B, Fathi M (2021). siRNA + regorafenib hybrid nanoparticles trigger apoptosis in regorafenib-resistant colon cancer.

Authors: Zhiani M, Mousavi MA, Rostamizadeh K, Pirizadeh R, Osali A, Mennati A, Motlagh B, Fathi M
Journal: American Journal of Cancer Research (2021)
DOI/Ref: PMC8085858
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085858/